Insights

Cloud single-cell Advaita Bio just launched iSCanGuide, a cloud-based platform for large-scale single-cell and spatial transcriptomics analysis. This presents a direct sales opportunity to biotech firms and CROs needing scalable, cloud-enabled analytics with AI-assisted workflows.

NIH funding Recent NIH grant of 1.7 million USD signals validated scientific merit and potential for platform expansion. This can open conversations with research institutes and life sciences companies seeking funded collaboration or co-development partnerships.

Enterprise reach Customer base includes life science, drug discovery, and biomedical research teams; their platform feeds into actionable pathway analysis. Opportunities exist to upsell to pharmaceutical firms and large biotech companies seeking integrated AI-assisted analytics across pipelines.

AI driven Two decades of validated algorithms powered by AI infrastructure position Advaita as a differentiator for mechanistic insights. Target enterprise buyers looking to accelerate move from data to mechanism and reduce manual analysis time.

Global partnerships Historical partnerships for distribution in ANZ and ongoing global research use imply appetite for channel expansion. Potential to engage systems integrators and distributors to scale adoption in new regions or verticals.

Similar companies to AdvaitaBio

AdvaitaBio Tech Stack

AdvaitaBio uses 8 technology products and services including Sage Intacct, LinkedIn Ads, HubSpot Analytics, and more. Explore AdvaitaBio's tech stack below.

Media & News

AdvaitaBio's Email Address Formats

AdvaitaBio uses at least 3 email formats:
AdvaitaBio Email FormatsExamplePercentage
First@advaitabio.comJohn@advaitabio.com
76%
First.Last@advaitabio.comJohn.Doe@advaitabio.com
12%
Last@advaitabio.comDoe@advaitabio.com
12%

Frequently Asked Questions

What is AdvaitaBio's official website and social media links?

Minus sign iconPlus sign icon
AdvaitaBio's official website is advaitabio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does AdvaitaBio generate?

Minus sign iconPlus sign icon
As of August 2026, AdvaitaBio's annual revenue is estimated to be $1M - $10M.

What is AdvaitaBio's SIC code and NAICS code?

Minus sign iconPlus sign icon
AdvaitaBio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AdvaitaBio have currently?

Minus sign iconPlus sign icon
As of August 2026, AdvaitaBio has approximately 19 employees across 2 continents, including North America and Asia. Key team members include Chief Operations Officer: R. M., Vice President Business Development: A. O. and Controller: J. B. Explore AdvaitaBio's employee directory with LeadIQ.

What industry does AdvaitaBio belong to?

Minus sign iconPlus sign icon
AdvaitaBio operates in the Biotechnology Research industry.

What technology does AdvaitaBio use?

Minus sign iconPlus sign icon
AdvaitaBio's tech stack includes Sage Intacct, LinkedIn Ads, HubSpot Analytics, Snowplow, Salesforce, Shopify, Mailchimp and PayPal.

What is AdvaitaBio's email format?

Minus sign iconPlus sign icon
AdvaitaBio's email format typically follows the pattern of First@advaitabio.com. Find more AdvaitaBio email formats with LeadIQ.

How much funding has AdvaitaBio raised to date?

Minus sign iconPlus sign icon
As of August 2026, AdvaitaBio has raised $1.2M in funding. The last funding round occurred on Aug 04, 2020 for $256K.

When was AdvaitaBio founded?

Minus sign iconPlus sign icon
AdvaitaBio was founded in 2007.
AdvaitaBio logo

AdvaitaBio

Biotechnology ResearchMichigan, United States11-50 Employees

Advaita Bio is a small to mid-sized biotechnology research company based in Ann Arbor, Michigan. It develops GPU-powered software for pathway analysis, variant interpretation, and single-cell and spatial analytics, used by researchers across life science, drug discovery, and biomedical research. The company combines two decades of validated algorithms with AI infrastructure to uncover biological insights that traditional tools may overlook. Its platforms are designed to help research teams translate complex data into mechanistic understanding.

Advaita's product lineup includes iScanGuide for single-cell RNA sequencing and spatial transcriptomics analysis, delivering cell type annotation and spatial context with reproducible results; outputs feed into iPathwayGuide. iPathwayGuide maps gene function and interactions across entire biological pathways to reflect how biology operates. iVariantGuide provides clinical and research variant interpretation by integrating ACMG guidelines, population data, and functional predictions to identify causal variants. In May 2026, the company announced the launch of iScanGuide as a cloud-based platform designed to handle large-scale single-cell and spatial datasets and generate biologically meaningful results.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $1.2M

    AdvaitaBio has raised a total of $1.2M of funding over 3 rounds. Their latest funding round was raised on Aug 04, 2020 in the amount of $256K as a Grant.

  • $1M - $10M

    AdvaitaBio's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.